Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etlingera elatior ethanol extract is a botanical extract derived from the fruit or flowers of Etlingera elatior (torch ginger), a plant widely used in traditional medicine and culinary applications. This extract contains active compounds such as vanillic acid and various phenolics and flavonoids, and exhibits significant antioxidant, anti-inflammatory, and potential nephroprotective (kidney-protective) activity in animal models of diabetes and diabetic nephropathy[1]. In preclinical studies, the ethanol extract has been shown to reduce high blood glucose, creatinine, and high-sensitivity C-reactive protein (hsCRP) levels, suggesting an anti-hyperglycemic and anti-hypertensive effect, as well as the ability to mitigate kidney inflammation and oxidative stress[1]. The extract is not a registered pharmaceutical or medical product and is used primarily in research or as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on etlingera elatior ethanol extract.